Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 1 |
---|
Ligand | BDBM275221 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | IMAP-FP Assay |
---|
IC50 | 0.18±n/a nM |
---|
Citation | Siliphaivanh, P; Methot, J; Lipford, KA; Molinari, D; Sloman, DL; Witter, D; Zhou, H; Boyce, C; Huang, X; Lim, J; Guerin, D; Karunakaran, GB; Bakshi, RK; Liu, Z; Fu, J; Wan, Z; Liu, W ERK inhibitors US Patent US9884048 Publication Date 2/6/2018 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 1 |
---|
Name: | Mitogen-activated protein kinase 1 |
Synonyms: | ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK |
Type: | Ser/Thr Protein Kinase |
Mol. Mass.: | 41392.76 |
Organism: | Homo sapiens (Human) |
Description: | P28482 |
Residue: | 360 |
Sequence: | MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE
HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH
LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH
TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI
LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK
RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
|
|
|
BDBM275221 |
---|
n/a |
---|
Name | BDBM275221 |
Synonyms: | 1-[(3R,4S)-1-methyl-4-(2- phenylethyl)pyrrolidin-3- yl]-3-[1-(2-methylpyridin-4- yl)-1H-pyrazolo[3,4-c]- pyridin-5-yl)urea | US9884048, Example 115 | US9884048, Example 185 |
Type | Small organic molecule |
Emp. Form. | C26H29N7O |
Mol. Mass. | 455.5548 |
SMILES | CN1C[C@H](CCc2ccccc2)[C@H](C1)NC(=O)Nc1cc2cnn(-c3ccnc(C)c3)c2cn1 |r| |
Structure |
|